|
The Mattson Jack Group (MattsonJack) is one of world’s leading full-service
consultancies focused entirely on the pharmaceutical and biotechnology industries.
MattsonJack provides services ranging from forecasting, market research, pricing
& reimbursement, and market access to technical assessment and licensing across
the full range of diseases in support of client needs. As part of this service,
MattsonJack has concentrated a broad team of specialists focused on cancer who support
high-quality custom engagements and multi-client consulting solutions through our
MattsonJack DaVinci oncology team. Through these services and specialization, MattsonJack
seeks to maximize the potential of our clients’ assets and to identify and
evaluate possible partnership opportunities.
|
MattsonJack products and services are available for the EU (25 country members and
Switzerland) through our full-time EU staff based in Paris and London
and our associates,
a member of MattsonJack International, LifeScience Consulting Group, International,
Karlsruhe, Germany.
|
|
|
|
Why MattsonJack?
Our available knowledge is EU-specific. Epi Database® - our
proprietary epidemiologic database - covers European countries. Our EU consultants
are well-skilled in forecasting and in oncology. Our licensing
team is a unique group supporting product identification and evaluation as well
as mergers and acquisitions all around the world and is regularly invited as key
speakers in international meetings.
Our forecasting expertise is actively represented through single-client
engagements conducted in the EU in cooperation with the U.S. team and through our
proprietary software productivity tool, Forecast Architect®.
Our oncology expertise is developed through
the promotion of CancerMPact®, Supportive Care Perspectives™,
and CancerNSight™, as well
as our oncology market access product
Oncology Marketing Strategies™ (OMS) for the U.S. and Western Europe.
How Can MattsonJack Serve You?
- For pharma or biotech companies
based in the EU, we can provide you with insights and strategies on key success
factors for drug launch, pricing, and uptake in the EU, the U.S. and Asia.
- For public or private healthcare insurance
companies, we can navigate your teams through the complexity of
the EU regulatory and market environment and help you manage your risks.
- For national, EU, or international
healthcare institutions, we can provide data, forecasts, and trends
about innovative and expensive drugs and protocols.
Over 500 companies and institutions have relied on MattsonJack as their catalyst
for growth, providing support to all levels of corporate decision-makers, line executives,
and business and technical experts. Clients respect us as their partner in augmenting
their in-house capabilities.
For more information on MattsonJack's European operations, contact:
Pierre Anhoury, M.D., M.P.H., H.R.M.,
Senior Vice President, Business Leader Europe
pierre.anhoury@mattsonjack.com
Tel: + 33(0)1 53 10 53 24
Mobile: +33(0)6 73 16 96 82
or e-mail info.europe@mattsonjack.com
|
